The Consortium for Technology Innovation in Pediatrics(CTIP) selected BioSense to join their prestigious FDA-funded Pediatric Device Consortium (PDC) at Children’s Hospital of Los Angeles.
The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) is a pediatric medical device accelerator centered at Children’s Hospital Los Angeles (CHLA) and the University of Southern California (USC). Established in 2011 and first funded by the U.S. Food and Drug Administration (FDA) in 2013, CTIP promotes the commercialization and clinical use of pediatric medical device technology. In August 2018, CTIP was awarded a new $6.6 million P50 grant from the FDA to continue research and development of MedTech for children (Grant Number: 1P50FD006425-01, PI: Espinoza).
CTIP addresses the most important component missing from pediatric device innovation: simultaneously engaging clinicians, engineers, regulators, hospital administrators, patients and the business community in the process of assessment and development of technology. For portfolio companies, CTIP fosters networking opportunities, direct and indirect financial support and guidance on issues related to, but not limited to, intellectual property, prototyping, engineering, testing, grant writing and clinical trial design. CTIP has a network of children’s hospitals, academic institutions, accelerators and incubators across the West Coast to support the commercialization of pediatric medical devices. CTIP network members include the University of California, Los Angeles; Oregon Health & Science University; University of Southern California; University of California, San Diego; University of California, Berkeley; Seattle Children’s Hospital; Cedars-Sinai Accelerator; The Lundquist Institute; Project Zygote and Larta Institute.